SecBot SecBot

PGNY

Progyny, Inc.
Nasdaq· Services-Misc Health & Allied Services, NEC· Inc. DE· CIK 0001551306 Healthcare & Medical Devices
$37.15 +0.97 (+2.68%)
Nov 16 4:00 PM ET · prev $36.18
Market cap
$2.7B
Mid cap
Consensus
Buy
83% Buy or better · 18 analysts
Median target
🔒 Subscribers only
1 year
+38.5%
from $26.82 · Nov 17
30 days
+33.4%
from $27.84
52-week range
$16.30–37.15
at the high
Avg volume 20D
1.08M
Nov 5 spike 2.79M
Short interest
4.76M
≈6.5% of shares · −1.9%
Days to cover
6.3
at average volume
Insider net
−$22.5M
0 buyers · 7 sellers · since Jun 1
New fund stakes
0
Q3 2026 13F · 3 exits
Filing reports
25
analyzed by SecBot
SecBot read MIXED 15 reports · 90 days
Balance 1 bearish · 2 bullish · 12 neutral oldest → newest, height = score
Avg score ·High conf. 13/15

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    7 insiders sold $22.5M.

  • InstitutionsMIXED

    Q3 2026: 19 added (0 new), 28 trimmed or exited.

  • AnalystsBULLISH

    15 of 18 rate it Buy or better.

  • Short sellersSTEADY

    Short interest −1.9% to 4.76M shares. 6.3 days to cover, ≈6.5% of shares.

  • TrendUPTREND

    29% above its 50-day average. New closing high $37.15 on Nov 16.

Who's buying

13F· Q3 2026
0
new positions
3
exits
FundMoveSharesValue
AMERICAN CENTURY COMPANIES INCDOUBLED2,584,543$65.1M
GEODE CAPITAL MANAGEMENT, LLCADD2,500,603$63.0M
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/TRIM1,636,371$41.2M
Neuberger Berman Group LLCDOUBLED562,507$14.2M
Qube Research & Technologies LtdDOUBLED489,804$12.3M
FIRST TRUST ADVISORS LPDOUBLED425,903$10.7M
RENAISSANCE TECHNOLOGIES LLCTRIM290,467$7.3M
SEI INVESTMENTS COADD205,402$5.2M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

18 analysts
Buy 83% rate it Buy or better
Strong Buy6Buy9Hold3Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Nov 9, 2026JP Morgan
MAINTAIN
MAINTAINNeutral
Nov 5, 2026Leerink Partners
MAINTAIN
MAINTAINOutperform
Nov 5, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Nov 5, 2026Citizens
MAINTAIN
MAINTAINMarket Outperform
Nov 5, 2026Cantor Fitzgerald
MAINTAIN
MAINTAINOverweight
Sep 30, 2026Wells Fargo
INITIATE
INITIATEOverweight

Insider ledger

Form 4
$0
bought · 0 insiders
$22.5M
sold · 7 insiders
DateInsiderTypeValue
Nov 11, 2026
Clapp Geoffrey
Chief Product Officer
Nov 11, 2026
SELL$28.2K
Nov 10, 2026
Schlanger David J
Executive Chairman
Nov 10, 2026
EXERCISE$32.2K
Nov 10, 2026
Schlanger David J
Executive Chairman
Nov 10, 2026
SELL$1.3M
Nov 10, 2026
Anevski Peter
CHIEF EXECUTIVE OFFICER
Nov 10, 2026
EXERCISE$168.5K
Nov 10, 2026
Anevski Peter
CHIEF EXECUTIVE OFFICER
Nov 10, 2026
SELL$4.3M
Nov 10, 2026
Anevski Peter
CHIEF EXECUTIVE OFFICER
Nov 10, 2026
SELL$2.4M
Nov 10, 2026
Anevski Peter
CHIEF EXECUTIVE OFFICER
Nov 10, 2026
SELL$1.2M
Nov 10, 2026
Anevski Peter
CHIEF EXECUTIVE OFFICER
Nov 10, 2026
SELL$655.3K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
4,758,154
shares short
-1.9%
vs prior settlement
6.3
days to cover
≈6.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 SEC
Four Progyny insiders, including the CEO, Executive Chairman, and CFO, sold shares in open-market transactions…
CLUSTER · Impact 2/10
Nov 12, 2026 SEC
Three PGNY insiders (CEO, Executive Chairman, CFO) sold a total of $10.33M in open-market sales over a 7-day window…
CLUSTER · Impact 4/10
Nov 12, 2026 SEC
Geoffrey Clapp, an officer of Progyny, filed a Form 144 notice of intent to sell 774 shares of common stock, valued at…
144 · Impact 2/10
Nov 11, 2026 Insider
Clapp Geoffrey sold 774 shares
Chief Product Officer @ $36.41 ($28.2K)
Nov 10, 2026 Insider
Schlanger David J acquired via exercise 35,392 shares
Executive Chairman @ $0.9100 ($32.2K)
Nov 10, 2026 Insider
Schlanger David J sold 35,392 shares
Executive Chairman @ $35.36 ($1.3M)
Nov 4, 2026 Earnings
Progyny, Inc. Announces Third Quarter 2026 Results
Reports Record Third Quarter Results for Revenue, Gross Profit, Adjusted EBITDA and Net Income Selli
Oct 26, 2026 Press
Progyny published a white paper showing that over 70% of members in its Menopause and Midlife program experienced…
Impact 2/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

25 filings · 1 press release · 2 bullish · 3 bearish · 20 neutral
All PGNY filing & press-release reports (26)